PSUSA/00001506/202304 - periodic safety update report single assessment

gadoteric acid (IV and intravascular formulations)

About

Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.

Key facts

• Active substance(s) in scope of the PSUSA procedure:
  gadoteric acid (IV and intravascular formulations)
• Procedure number:
  PSUSA/00001506/202304
• Regulatory outcome:
  Variation

Documents

Gadoteric acid (IV and intravascular formulations) : List of nationally authorised medicinal products - PSUSA/00001506/202304

Reference Number: EMA/95353/2024

Gadoteric acid (IV and intravascular formulations) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001506/202304